Strata Skin Sciences, Inc. (NASDAQ:SSKN)‘s stock had its “buy” rating reaffirmed by research analysts at HC Wainwright in a research note issued on Thursday, September 7th.
SSKN has been the topic of a number of other reports. Rodman & Renshaw increased their price target on Strata Skin Sciences from $1.50 to $12.00 and gave the stock a “buy” rating in a report on Tuesday, May 16th. ValuEngine raised Strata Skin Sciences from a “strong sell” rating to a “sell” rating in a research report on Friday, June 16th. Finally, Zacks Investment Research lowered Strata Skin Sciences from a “hold” rating to a “sell” rating in a research report on Wednesday, August 16th.
Shares of Strata Skin Sciences (NASDAQ:SSKN) traded up 4.14% during trading on Thursday, hitting $1.76. 18,391 shares of the company’s stock were exchanged. The firm’s market capitalization is $4.36 million. Strata Skin Sciences has a 1-year low of $0.43 and a 1-year high of $5.40. The stock’s 50 day moving average is $1.74 and its 200 day moving average is $2.03.
Strata Skin Sciences (NASDAQ:SSKN) last announced its earnings results on Thursday, August 10th. The medical device company reported ($0.52) EPS for the quarter, beating the Thomson Reuters’ consensus estimate of ($0.71) by $0.19. Strata Skin Sciences had a negative return on equity of 41.58% and a negative net margin of 18.00%. The business had revenue of $8.70 million for the quarter, compared to analysts’ expectations of $7.98 million. On average, equities research analysts forecast that Strata Skin Sciences will post ($3.14) earnings per share for the current year.
About Strata Skin Sciences
STRATA Skin Sciences, Inc, formerly MELA Sciences, Inc, is a medical technology company. The Company is engaged in developing and commercializing products for the diagnosis and treatment of dermatological disorders. The Company has three segments: Dermatology Recurring Procedures, Dermatology Procedures Equipment and Dermatology Imaging.
Receive News & Ratings for Strata Skin Sciences Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Strata Skin Sciences Inc. and related companies with our FREE daily email newsletter.